Natural Capsules Stock Screener | Share Price & Fundamental Analysis
NATCAPSUQ
Pharmaceuticals
Screen Natural Capsules share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹180.14
▼
-6.61 (-3.54%)
Share Price BSE
₹179.00
▼
-9.90 (-5.24%)
Market Cap
₹188.21 Cr.
P/E Ratio (TTM)
-16.35
P/B Ratio
0.86
EPS (TTM)
₹0.23
Dividend Yield
-
Debt to Equity
0.49
52W High
₹278.00
52W Low
₹166.00
Operating Margin
10.00%
Profit Margin
2.22%
Revenue (TTM)
₹45.00
EBITDA
₹5.00
Net Income
₹1.00
Total Assets
₹419.00
Total Equity
₹257.00
Natural Capsules Share Price History - Stock Screener Chart
Screen NATCAPSUQ historical share price movements with interactive charts. Analyze price trends and patterns.
Natural Capsules Company Profile - Fundamental Screener
Screen Natural Capsules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NATCAPSUQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE936B01015
Natural Capsules Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen NATCAPSUQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 419 | 377 | 289 | 164 | 97 | 75 | 73 | 71 |
| Current Assets | 130 | 124 | 102 | 76 | 50 | 38 | 38 | 42 |
| Fixed Assets | 284 | 103 | 97 | 67 | 38 | 24 | 24 | 22 |
| Liabilities | ||||||||
| Total Liabilities | 419 | 377 | 289 | 164 | 97 | 75 | 73 | 71 |
| Current Liabilities | 62 | 71 | 74 | 37 | 2 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 257 | 229 | 148 | 83 | 62 | 56 | 56 | 54 |
| Share Capital | 10 | 9 | 9 | 7 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 223 | 195 | 114 | 76 | 56 | 49 | 49 | 48 |
Screen NATCAPSUQ income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45 | 46 | 46 | 41 | 39 | 41 | 44 | 38 | 38 | 38 | 41 | 42 | 44 | 45 | 46 |
| Expenses | 41 | 45 | 47 | 36 | 35 | 37 | 40 | 32 | 32 | 32 | 35 | 33 | 35 | 35 | 36 |
| EBITDA | 5 | 1 | -1 | 5 | 5 | 5 | 4 | 6 | 6 | 6 | 5 | 9 | 9 | 10 | 10 |
| Operating Profit % | 10.00% | 1.00% | -2.00% | 10.00% | 11.00% | 11.00% | 10.00% | 15.00% | 16.00% | 14.00% | 12.00% | 20.00% | 21.00% | 21.00% | 21.00% |
| Depreciation | 2 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Interest | 2 | 3 | 3 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | -6 | -8 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 7 | 7 | 7 | 7 |
| Tax | 0 | -1 | -1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Net Profit | 1 | -6 | -7 | 1 | 1 | -1 | 0 | 2 | 2 | 2 | 1 | 5 | 5 | 5 | 5 |
| EPS | 0.13 | -5.40 | -6.76 | 1.31 | 0.65 | -0.60 | 0.10 | 1.85 | 1.96 | 1.67 | 1.29 | 7.02 | 7.43 | 6.85 | 5.68 |
Natural Capsules Cash Flow Screener - Liquidity Fundamentals
Screen NATCAPSUQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 27 | -8 | 17 | -1 | 6 | 7 | 2 | 5 |
| Investing Activities | -45 | -73 | -105 | -46 | -9 | -6 | -7 | -1 |
| Financing Activities | 16 | 82 | 88 | 48 | 3 | -1 | 4 | -4 |
| Net Cash Flow | -2 | 1 | 0 | 1 | 0 | 0 | -1 | 1 |
Screen NATCAPSUQ shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Nov |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.14% | 51.21% | 51.26% | 51.26% | 56.56% | 56.56% | 51.60% | 51.14% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 1.31% | 0.18% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.86% | 33.09% | 33.04% | 32.94% | 34.72% | 35.10% | 32.26% | 32.85% |
| Other Holding | 16.01% | 15.70% | 15.69% | 15.80% | 7.41% | 8.16% | 16.14% | 16.02% |
| Shareholder Count | 9,552 | 9,425 | 9,311 | 9,573 | 10,954 | 10,514 | 9,995 | 9,726 |
Natural Capsules Dividend Screener - Share Yield Analysis
Screen NATCAPSUQ dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Natural Capsules Index Membership - Market Screener Classification
Screen NATCAPSUQ by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Natural Capsules Market Events Screener - Corporate Actions
Screen NATCAPSUQ market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | 29.27% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.85% |
| 2025-08-04 | 2025-08-04 | Annual General Meeting | NA | -3.27% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -0.46% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 2.49% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -10.56% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -4.42% |
| 2024-08-23 | 2024-08-23 | Extraordinary General Meeting | NA | -5.93% |
| 2024-07-26 | 2024-07-26 | Annual General Meeting | NA | 9.84% |
| 2023-07-20 | 2023-07-20 | Dividend | ₹ 1.00 /share | -19.69% |
| 2021-11-11 | 2021-11-12 | Rights | 1:2 | 33.36% |
| 2021-07-06 | 2021-07-08 | Dividend | ₹ 1.00 /share | 1.21% |
Natural Capsules Competitors Screener - Peer Comparison
Screen NATCAPSUQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 423,459 | 40.79 | 54,729 | 9.71% | 10,980 | 58.99 |
| Divis Laboratories | 176,218 | 70.95 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 136,746 | 64.70 | 11,539 | 6.99% | 1,911 | 80.95 |
| Cipla | 118,161 | 21.81 | 28,410 | 7.12% | 5,291 | 38.52 |
| Dr Reddys Laboratories | 101,124 | 18.08 | 33,741 | 16.73% | 5,725 | 40.17 |
| Lupin | 100,482 | 23.26 | 22,910 | 13.74% | 3,306 | 71.67 |
| Mankind Pharma | 93,538 | 53.80 | 12,744 | 20.90% | 2,007 | 64.16 |
| Zydus Life Science | 91,995 | 18.55 | 23,511 | 18.55% | 4,615 | 52.14 |
| Aurobindo Pharma | 70,434 | 20.97 | 32,346 | 9.43% | 3,484 | 61.25 |
| Alkem Laboratories | 69,330 | 28.72 | 13,458 | 3.70% | 2,216 | 63.97 |
Natural Capsules Company Announcements - News Screener
Screen NATCAPSUQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Announcement Under Regulation 30(9) Of SEBI (LODR) Regulations 2015 | View |
| 2025-12-26 | Announcement Under Regulation 30 Of SEBI( LODR) Regulations 2015 | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Announcement Under Regulation 30 | View |
| 2025-11-13 | Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-03 | Board Meeting Intimation for Approval Of Un-Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations 2015. | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Retirement | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-23 | Clarification With Respect To Significant Movement In The Price Of Security | View |